Monopar Therapeutics Inc.

MNPR ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2018

Total Assets: $7.3M

Liabilities Breakdown FY2018

Total Liabilities: $399.6K